Valuation: Boule Diagnostics AB

Market Cap 136M 14.24M 12.33M 11.56M 10.54M 19.82M 1.36B 20.12M 53.13M 680M 53.45M 52.29M 2.27B P/E 2026 *
-13.9x
P/E 2027 * 15.8x
Enterprise Value 332M 34.82M 30.17M 28.27M 25.78M 48.47M 3.32B 49.22M 130M 1.66B 131M 128M 5.55B EV / Sales 2026 *
0.73x
EV / Sales 2027 * 0.66x
Free-Float
53.64%
Yield 2026 *
-
Yield 2027 * -
1 day-0.57%
1 week-2.78%
Current month-8.38%
1 month-8.14%
3 months+8.36%
6 months-21.17%
Current year-28.72%
1 week 3.46
Extreme 3.46
3.66
1 month 2.75
Extreme 2.75
3.95
Current year 2.75
Extreme 2.75
5.68
1 year 2.75
Extreme 2.75
6.64
3 years 2.75
Extreme 2.75
12.62
5 years 2.75
Extreme 2.75
61.2
10 years 2.75
Extreme 2.75
108.88
Manager TitleAgeSince
Chief Executive Officer - 2026-06-21
Director of Finance/CFO 54 2026-02-10
Chief Tech/Sci/R&D Officer - 2018-12-31
Director TitleAgeSince
Director/Board Member 59 2013-12-31
Chairman 73 2020-12-31
Chairman 74 2022-12-31
Date Insider Type Main position Quantity % Market Cap.
2/27/23 Buy

Chief Financial Officer

8,000 0.0206%
2/6/23 Buy

Director

7,083 0.0182%
2/17/22 Buy

Director

2,000 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
-0.57%-2.78%-43.55%-64.61% 14.37M
-0.33%+4.36%+26.31%+10.89% 224B
-0.80%+3.07%+0.03%-19.43% 146B
+0.01%+6.95%-16.09%+31.78% 142B
+0.45%+7.71%-49.90%+0.76% 74.19B
-0.65%+4.59%+20.95%+17.18% 53.99B
-1.41%-0.54%-15.65%-17.29% 50.85B
-0.84%+5.05%+26.36%+16.85% 42.22B
+0.28%+4.04%+45.75%+42.68% 40.75B
-0.65%+2.90%-2.86%+0.96% 32.86B
Average -0.45%+2.83%-0.86%+1.98% 80.61B
Weighted average by Cap. -0.37%+4.55%+3.88%+8.30%

Financials

2026 *2027 *
Net sales 453M 47.46M 41.12M 38.53M 35.14M 66.06M 4.53B 67.08M 177M 2.27B 178M 174M 7.56B 483M 50.62M 43.86M 41.09M 37.48M 70.47M 4.83B 71.55M 189M 2.42B 190M 186M 8.06B
Net income -9.77M -1.02M -887K -831K -758K -1.42M -97.63M -1.45M -3.82M -48.89M -3.84M -3.76M -163M 8.6M 900K 780K 731K 667K 1.25M 85.88M 1.27M 3.36M 43M 3.38M 3.31M 143M
Net Debt 197M 20.59M 17.84M 16.71M 15.24M 28.66M 1.96B 29.1M 76.83M 983M 77.29M 75.61M 3.28B 185M 19.33M 16.74M 15.69M 14.31M 26.9M 1.84B 27.32M 72.13M 923M 72.56M 70.98M 3.08B
Logo Boule Diagnostics AB
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company’s product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company’s primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
Employees
200
Date Price Change Volume
26-08-12 SEK 3.500 -0.57% 4,200
26-08-11 SEK 3.520 -2.22% 7,165
26-08-10 SEK 3.600 0.00% 10,063
26-08-07 SEK 3.600 +1.12% 19,801
26-08-06 SEK 3.560 -1.11% 6,662
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3.500SEK
Average target price
3.800SEK
Spread / Average Target
+8.57%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BOUL Stock